By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Statistics

Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD


Company News
Gilead (GILD) To Present At The Bernstein 31st Annual Strategic Decisions Conference On Thursday, May 28 5/28/2015 10:49:34 AM
European Medicines Agency Validates Gilead (GILD)’s Marketing Application For Fixed-Dose Combination Of Emtricitabine And Tenofovir Alafenamide For HIV Treatment 5/28/2015 10:47:35 AM
Gilead (GILD) Will Hire Up to 170 Scientists in $100 Million Edmonton Expansion 5/28/2015 5:57:48 AM
Gilead (GILD)’s Hep B Trial Failure Will Inspire M&A Activity, Say Analysts 5/28/2015 5:45:38 AM
Gilead (GILD), GlobeImmune (GBIM)'s Hep B Drug Flunks Phase II Study 5/27/2015 6:09:10 AM
As Market Roars, Gilead (GILD) Looking for "Value-Added" Deals, Says CFO 5/22/2015 8:42:17 AM
Gilead (GILD) CFO Says Reliance On Outsourcing Helped It Bump Eli Lilly (LLY) Out of Top 10 Ranking 5/22/2015 6:46:14 AM
I-MAK Release: Patent Challenges In Five Countries Dispute Validity Of Gilead (GILD)'s Claims To Hep C Drug Patents That Block Treatment For Up To 59 Million People 5/20/2015 7:49:16 AM
Achillion (ACHN), Johnson & Johnson (JNJ) Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead (GILD) and AbbVie (ABBV) 5/19/2015 3:42:55 PM
Gilead (GILD) To Present At The UBS 2015 Global Healthcare Conference On Tuesday, May 19 5/19/2015 12:20:29 PM